8don MSN
For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...
A European regulatory committee has rejected Eli Lilly's U.S.-approved Alzheimer's disease treatment over potentially ...
An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...
A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that ...
TheHyperHive on MSN2d
Is Alzheimer’s a Brain Disease? Science Says “No”!For years, Alzheimer’s disease has been considered a brain disorder that leads to memory loss and cognitive decline. It’s a ...
The brain's immune cells removed plaques and helped restore a healthier environment in the brains of immunized patients. For over 30 years, scientists have focused on treating Alzheimer’s disease by ...
The European Medicines Agency has rejected Lilly’s Alzheimer’s drug Kisunla for a license, saying its benefits don’t outweigh ...
For the study, the researchers gave the study participants an experimental anti-amyloid drug. They found that 22 participants ...
Research shows experimental anti-amyloid drug reduced cognitive symptom risk by 50% in people with rare genetic mutations ...
A bioengineer highlights the potential of low-intensity ultrasound for multiple uses, from enhanced drug delivery to the ...
EatingWell on MSN1d
Your Dementia Risk May Be Increased by Another Disease Diagnosis—Here’s How to Prevent ItIf you’re in your 30s, 40s or 50s, dementia might feel like a distant concern, something you associate with advanced age.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback